NORTHERN CANCER CARE & RESEARCH SOCIETY

Charity overview
Activities - how the charity spends its money
Supports research into gynaecological cancers and directly supports improvements in the care identified by its own and other research to deliver up to date and best outcomes for patients.
Income and expenditure
Data for financial year ending 31 March 2024
People

5 Trustee(s)
Employees with total benefits over £60,000
No information availableFundraising
Trading
Trustee payments
What, who, how, where
- General Charitable Purposes
- Education/training
- The Advancement Of Health Or Saving Of Lives
- Other Defined Groups
- Makes Grants To Individuals
- Makes Grants To Organisations
- Provides Other Finance
- Provides Advocacy/advice/information
- Sponsors Or Undertakes Research
- Throughout England And Wales
Governance
- 23 May 2018: CIO registration
- 04 July 2024: Funds received from 514392 NORTHERN CANCER CARE AND RESEARCH SOCIETY
- NORTHERN CANCER CARE AND RESEARCH SOCIETY (Previous name)
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Investment
- Risk management
Trustees
Trustees are the people responsible for controlling the work, management and administration of the charity on behalf of its beneficiaries. Generally trustees are treasurer, chair, board member etc. The trustees are responsible for keeping this list up to date and can do this by updating their details as they happen through the online service
5 Trustee(s)
Name | Role | Date of appointment | Other trusteeships | Reporting status of other trusteeships | ||||
---|---|---|---|---|---|---|---|---|
KEITH ARTHUR GODFREY | Chair | 25 May 2018 |
|
|
||||
Dr Christine Ang | Trustee | 01 April 2022 |
|
|
||||
Dr Nithya Ratnavelu | Trustee | 01 April 2022 |
|
|
||||
Ali Kucukmetin | Trustee | 28 May 2018 |
|
|
||||
HELEN JANE MANDERVILLE RGN | Trustee | 28 May 2018 |
|
|
Financial history
Financial period end date
Income / Expenditure | 31/03/2020 | 31/03/2021 | 31/03/2022 | 31/03/2023 | 31/03/2024 | ||
---|---|---|---|---|---|---|---|
|
Total gross income | £0 | £0 | £0 | £0 | £254.92k | |
|
Total expenditure | £0 | £0 | £0 | £0 | £32.24k | |
|
Income from government contracts | N/A | N/A | N/A | N/A | N/A | |
|
Income from government grants | N/A | N/A | N/A | N/A | N/A |
Accounts and annual returns
Title | Reporting year | Date received | Received | Download |
---|---|---|---|---|
Annual return | 31 March 2024 | 20 December 2024 | On Time | |
Accounts and TAR | 31 March 2024 | 20 December 2024 | On Time | Download Open in new window |
Annual return | 31 March 2023 | 29 January 2024 | On Time | |
Accounts and TAR | 31 March 2023 | 29 January 2024 | On Time | Download Open in new window |
Annual return | 31 March 2022 | 21 March 2023 | 49 days late | |
Accounts and TAR | 31 March 2022 | 21 March 2023 | 49 days late | Download Open in new window |
Annual return | 31 March 2021 | 04 April 2022 | 63 days late | |
Accounts and TAR | 31 March 2021 | 21 March 2023 | 414 days late | Download Open in new window |
Annual return | 31 March 2020 | 04 April 2022 | 428 days late | |
Accounts and TAR | 31 March 2020 | 21 March 2023 | 779 days late | Download Open in new window |
Governing document
It is not the full text of the charity's governing document.
CIO - FOUNDATION Registered 23 May 2018
Charitable objects
FOR THE PROMOTION OF RESEARCH INTO MATTERS RELATING TO THE DIAGNOSIS AND TREATMENT OF CANCERS IN WOMEN AND EDUCATION WHETHER OF MEMBERS OF THE MEDICAL AND NURSING PROFESSIONS OR OF THE GENERAL PUBLIC IN THE MEANS OF SUCH DIAGNOSIS AND TREATMENT OF THE AFORESAID.
Contact information
- Address:
-
NORTHERN GYNAECOLOGICAL ONCOLOGY CE
Queen Elizabeth Hospital
GATESHEAD
NE9 6SX
- Phone:
- 01914453404
- Email:
- KEITHAGODFREY1@GMAIL.COM
- Website:
-
No information available
Tell us whether you accept cookies
We use cookies to collect information about how you use your Charity Commission Account, such as pages you visit.
We use this information to better understand how you use our website so that we can improve your user experience and present more relevant content.
Thank you for your feedback. Do you have 5 minutes to tell us what you think of this service?Open in new window